Although our nation’s healthcare is often seen as too costly, it is credited with many important medical innovations. And benefits accrue to people not just here in the United States, but around the world. #-ad_banner-#Take obstructive sleep apnea, as an example. The common and insidious sleep disorder, in which breathing briefly stops dozens of times during the night, affects 25 million Americans and 100 million people globally. The prevalence could climb much higher due to rising rates of obesity, a chief sleep apnea risk factor. Although sleep apnea is most commonly associated with snoring, it’s a major… Read More
Although our nation’s healthcare is often seen as too costly, it is credited with many important medical innovations. And benefits accrue to people not just here in the United States, but around the world. #-ad_banner-#Take obstructive sleep apnea, as an example. The common and insidious sleep disorder, in which breathing briefly stops dozens of times during the night, affects 25 million Americans and 100 million people globally. The prevalence could climb much higher due to rising rates of obesity, a chief sleep apnea risk factor. Although sleep apnea is most commonly associated with snoring, it’s a major health problem. Sleep apena sufferers have a higher risk of heart disease, stroke and daytime fatigue that is severe enough to cause people to fall asleep at the wheel. Such consequences have spurred massive and growing demand for the devices used to detect and treat sleep apnea. The market for treatments is on pace to expand to $19.7 billion by 2017, from $8 billion in 2011, according to India-based research firm MarketsandMarkets. Many publicly traded companies are jumping on this trend. But my favorite is ResMed, Inc. (NYSE: RMD), a mid-sized medical device firm with nearly three decades… Read More